Logo
x

Search

Subscribe Now

cystic fibrosis

Vertex's Kaftrio (ivacaftor/tezacaftor/elexacaftor) + Ivacaftor Receives CHMP's Positive Opinion for the Treatment of Cystic Fibrosis in Children Aged 6 to 11

Vertex's Kaftrio (ivacaftor/tezacaftor/elexacaftor) + Ivacaftor Receives CHMP's Positive Opinion for the Treatment of Cystic Fibro...

  • November 15, 2021
Vertex's Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) Receives the US FDA's Approval in Children Aged 6 to 11 with Certain Mutations in Cystic Fibrosis

Vertex's Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) Receives the US FDA's Approval in Children Aged 6 to 11 with Ce...

  • June 10, 2021
AzurRx BioPharma Reports Positive Interim P-II Data of MS1819 + PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

AzurRx BioPharma Reports Positive Interim P-II Data of MS1819 + PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic...

  • May 14, 2021
Chiesi's Bronchitol (mannitol) Inhalation Powder Receives the US FDA's Approval for Cystic Fibrosis

Chiesi's Bronchitol (mannitol) Inhalation Powder Receives the US FDA's Approval for Cystic Fibrosis

  • November 19, 2020
Vertex's Kaftrio + Ivacaftor Receive the EC's Approval to Treat Cystic Fibrosis in People Aged 12 Years and Older

Vertex's Kaftrio + Ivacaftor Receive the EC's Approval to Treat Cystic Fibrosis in People Aged 12 Years and Older

  • August 24, 2020
Vertex's Kalydeco (ivacaftor) Receives EC's Approval for Infants with Cystic Fibrosis with CFTR Gene Mutation Aged 6 to

Vertex's Kalydeco (ivacaftor) Receives EC's Approval for Infants with Cystic Fibrosis with CFTR Gene Mutation Aged 6 to

  • December 11, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.